| Number of patients, n | Number of AIDS, n | % | Univariable analysis, crude HR (95% CI) | Multivariable analysis, adjusted HR (95% CI) |
---|---|---|---|---|---|
Age group | |||||
  ≤ 30 | 9826 | 843 | 8.6 | 1.0 (Reference) | 1.0 (Reference) |
 31–40 | 5312 | 442 | 8.3 | 0.97 (0.87–1.09) | 1.17 (1.04–1.32)** |
 41–50 | 2028 | 227 | 11.2 | 1.35 (1.16–1.56)*** | 1.68 (1.44–1.96)*** |
  ≥ 51 | 737 | 127 | 17.2 | 2.19 (1.82–2.64)*** | 2.36 (1.90–2.92)*** |
Sex | |||||
 Female | 1302 | 96 | 7.4 | 1.0 (Reference) | 1.0 (Reference) |
 Male | 16,601 | 1543 | 9.3 | 1.26 (1.03–1.55)* | 1.16 (0.93–1.44) |
HIV-transmission route | |||||
 PWID | 6435 | 361 | 5.6 | 1.0 (Reference) | 1.0 (Reference) |
 Bisexual contact | 1322 | 148 | 11.2 | 2.05 (1.69–2.48)*** | 2.62 (2.11–3.24)*** |
 Heterosexual contact | 2496 | 312 | 12.5 | 2.33 (2.00–2.71)*** | 2.79 (2.35–3.31)*** |
 Homosexual contact | 7602 | 808 | 10.6 | 1.94 (1.71–2.19)*** | 2.58 (2.19–3.03)*** |
 Othera | 48 | 10 | 20.8 | 4.92 (2.62–9.22)*** | 4.90 (2.58–9.31)*** |
Urbanization | |||||
 Rural | 6038 | 557 | 9.2 | 1.0 (Reference) | 1.0 (Reference) |
 Urban | 11,865 | 1082 | 9.1 | 0.99 (0.89–1.09) | 0.93 (0.83–1.04) |
Income level, n (%) | |||||
 Low | 11,323 | 950 | 8.4 | 1.0 (Reference) | 1.0 (Reference) |
 Intermediate | 4833 | 508 | 10.5 | 1.26 (1.13–1.41)*** | 0.97 (0.86–1.08) |
 High | 1747 | 181 | 10.4 | 1.24 (1.06–1.46)** | 0.84 (0.71–0.99)* |
Cohort period | |||||
 Period 1 | 957 | 43 | 4.5 | 1.0 (Reference) | 1.0 (Reference) |
 Period 2 | 1777 | 68 | 3.8 | 0.85 (0.58–1.24) | 0.82 (0.56–1.21) |
 Period 3 | 6890 | 559 | 8.1 | 1.84 (1.35–2.51)*** | 3.32 (2.42–4.56)*** |
 Period 4 | 3976 | 458 | 11.5 | 2.67 (1.95–3.65)*** | 3.53 (2.57–4.84)*** |
 Period 5 | 4303 | 511 | 11.9 | 2.76 (2.02–3.76)*** | 3.04 (2.22–4.17)*** |
Region | |||||
 Taipei area | 6166 | 526 | 8.5 | 1.0 (Reference) | 1.0 (Reference) |
 Northern Taiwan | 2581 | 279 | 10.8 | 1.28 (1.11–1.48)*** | 1.41 (1.22–1.64)*** |
 Central Taiwan | 3209 | 275 | 8.6 | 1.00 (0.87–1.16) | 1.06 (0.91–1.23) |
 Southern Taiwan | 2137 | 197 | 9.2 | 1.09 (0.92–1.28) | 1.17 (0.98–1.38) |
 Kaoping area | 3466 | 324 | 9.4 | 1.10 (0.96–1.27) | 1.14 (0.98–1.32) |
 Eastern Taiwan | 344 | 38 | 11.1 | 1.30 (0.94–1.81) | 1.16 (0.82–1.64) |
DM | |||||
 No | 17,556 | 1590 | 9.1 | 1.0 (Reference) | 1.0 (Reference) |
 Yes | 347 | 49 | 14.1 | 1.69 (1.27–2.25)*** | 1.08 (0.79–1.46) |
CKD | |||||
 No | 17,717 | 1610 | 9.1 | 1.0 (Reference) | 1.0 (Reference) |
 Yes | 186 | 29 | 15.6 | 1.89 (1.31–2.73)*** | 1.49 (1.02–2.17)* |
CHF | |||||
 No | 17,861 | 1630 | 9.1 | 1.0 (Reference) | 1.0 (Reference) |
 Yes | 42 | 9 | 21.4 | 2.82 (1.46–5.43)** | 1.81 (0.92–3.58) |
COPD | |||||
 No | 17,626 | 1604 | 9.1 | 1.0 (Reference) | 1.0 (Reference) |
 Yes | 277 | 35 | 12.6 | 1.47 (1.05–2.05)* | 1.00 (0.71–1.41) |
Cancer | |||||
 No | 16,788 | 1506 | 9.0 | 1.0 (Reference) | 1.0 (Reference) |
 Yes | 1115 | 133 | 11.9 | 1.38 (1.15–1.64)*** | 1.09 (0.91–1.31) |
CVD | |||||
 No | 17,765 | 1622 | 9.1 | 1.0 (Reference) | 1.0 (Reference) |
 Yes | 138 | 17 | 12.3 | 1.47 (0.91–2.36) | 1.01 (0.62–1.65) |
HAART during follow-up period | |||||
 No | 5173 | 120 | 2.3 | 1.0 (Reference) | 1.0 (Reference) |
 Yes | 12,730 | 1519 | 11.9 | 1.43 (1.29–1.59)*** | 1.29 (1.15–1.44)*** |